Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Jayant Agro-Organics is an India-based specialty chemicals manufacturer focused on castor oil derivatives and value-added products serving industrial applications across pharmaceuticals, cosmetics, lubricants, and polymers. The company operates integrated crushing facilities processing castor seeds into refined oils, fatty acids, and specialty derivatives, with significant exposure to global commodity cycles and Indian agricultural supply chains. Its competitive position derives from vertical integration from seed procurement through derivative production, though margins remain compressed by raw material volatility and commodity-like pricing in base products.
The company generates margins through vertical integration, purchasing castor seeds from Indian farmers (India produces 70%+ of global castor), crushing them in owned facilities, and refining into progressively higher-value derivatives. Base castor oil operates on thin 3-5% margins as a commodity, while specialty derivatives command 15-25% gross margins due to technical specifications for pharmaceutical and industrial applications. Pricing power is limited in base products but moderate in specialty grades where customer qualification cycles create switching costs. The 15.9% gross margin suggests a mix weighted toward mid-tier products rather than highest-value specialty chemicals.
Castor seed prices and availability - Indian monsoon patterns, Gujarat/Rajasthan crop yields directly impact raw material costs (60-70% of COGS)
Global castor oil derivative demand - industrial production in end markets (automotive lubricants, cosmetics, pharmaceuticals) drives volume growth
Specialty product mix shift - movement from commodity castor oil toward higher-margin derivatives (12-HSA, sebacic acid) expands margins
USD/INR exchange rate - significant export exposure (estimated 40-50% of sales) creates currency translation gains/losses
Crude oil prices - affects competitive positioning versus petroleum-based alternatives in lubricants and polymers
Agricultural supply concentration - 85%+ dependence on Indian castor production creates monsoon/climate risk and single-geography exposure versus diversified chemical peers
Commodity substitution risk - synthetic alternatives from petrochemicals can displace bio-based castor derivatives in price-sensitive applications (lubricants, plasticizers) when crude oil prices decline below $60-65/barrel
Limited pricing power in base products - castor oil trades as global commodity with transparent pricing, restricting margin expansion without product mix shift toward specialty derivatives
Chinese competition in derivative markets - Chinese producers have expanded sebacic acid and specialty derivative capacity, pressuring export pricing in key markets
Customer backward integration - Large pharmaceutical and cosmetic companies may source castor oil directly and produce derivatives in-house, disintermediating specialty chemical suppliers
Scale disadvantage versus global oleochemical majors - Companies like Croda, Evonik operate larger scale with broader product portfolios and R&D capabilities
Working capital volatility - Castor seed price spikes can rapidly consume cash (e.g., 30-40% price increases during poor harvests), stressing liquidity despite 2.07x current ratio
Currency mismatch - Export revenues in USD/EUR versus INR costs create translation exposure, though natural hedge exists if crude oil (input cost proxy) correlates with USD strength
moderate-to-high - Demand for castor derivatives correlates with industrial production in end markets (automotive, construction, manufacturing). Pharmaceutical and cosmetic applications provide some counter-cyclical stability (estimated 30-40% of demand), but lubricants, coatings, and polymer applications are highly cyclical. The 19.4% revenue growth during recent expansion periods demonstrates cyclical leverage, while -30.5% stock decline suggests market anticipates industrial slowdown.
Moderate impact through two channels: (1) Working capital financing costs are material given 90-120 day inventory cycles for agricultural commodities and receivables in export markets, with 0.33x debt/equity indicating manageable but present leverage; (2) Valuation multiple compression as rising rates reduce appeal of 0.4x P/S, 10.8x EV/EBITDA multiples. The 2.07x current ratio suggests adequate liquidity buffer against rate increases.
Moderate - The company requires seasonal working capital facilities to finance castor seed procurement during harvest seasons (October-March in India) and maintain inventory through processing cycles. Export receivables create 60-90 day credit exposure to international customers. However, 0.33x debt/equity and strong 2.07x current ratio indicate conservative leverage and minimal refinancing risk.
value - The 0.4x P/S, 0.9x P/B, and 10.5% FCF yield attract value investors seeking commodity-exposed specialty chemicals at cyclical troughs. The -30.5% one-year decline and depressed multiples suggest deep value positioning, though 2.2% net margin and 7.5% ROE indicate operational challenges limiting quality characteristics. Not suitable for growth investors given commodity exposure and limited margin expansion visibility.
high - Agricultural commodity exposure, export currency fluctuations, and cyclical end-market demand create significant earnings volatility. The -18.8% three-month and -26.9% six-month declines demonstrate high beta to industrial cycle expectations. Monsoon variability and castor seed price swings (30-50% annual ranges historically) amplify quarterly result unpredictability.